Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Newman

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Bulletin of the World Health Organization|December 11, 2012
Decision-making on malaria vaccine introduction: the role of cost-effectiveness analysesVasee S Moorthy, Raymond Hutubessy, Robert D Newman, et al.
Malaria Journal|January 16, 2013
Progress towards malaria control targets in relation to national malaria programme fundingEline L Korenromp, Mehran Hosseini, Robert D Newman, et al.
Current Opinion in Infectious Diseases|November 3, 2007
Intermittent preventive therapy for malaria: progress and future directionsMartin P Grobusch, Andrea Egan, Roly D Gosling, et al.
Annals of Internal Medicine|October 7, 2004
Malaria-related deaths among U.S. travelers, 1963-2001Robert D Newman, Monica E Parise, Ann M Barber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002Louise M Causer, Scott Filler, Marianna Wilson, et al.
Drug Safety|June 1, 2007
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatmentPhilip J Peters, Michael C Thigpen, Monica E Parise, et al.
Tropical Medicine & International Health : TM & IH|June 7, 2003
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan AfricaRobert D Newman, Monica E Parise, Laurence Slutsker, et al.
Lancet (London, England)|January 27, 2009
Neglected tropical diseases and the Global FundDavid H Molyneux, Peter J Hotez, Alan Fenwick, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|November 8, 2002
Malaria surveillance--United States, 1999Robert D Newman, Ann M Barber, Jacquelin Roberts, et al.
The Lancet. Infectious Diseases|January 26, 2007
Epidemiology and burden of malaria in pregnancyMeghna Desai, Feiko O ter Kuile, François Nosten, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Bulletin of the World Health Organization|December 11, 2012
Decision-making on malaria vaccine introduction: the role of cost-effectiveness analysesVasee S Moorthy, Raymond Hutubessy, Robert D Newman, et al.
Malaria Journal|January 16, 2013
Progress towards malaria control targets in relation to national malaria programme fundingEline L Korenromp, Mehran Hosseini, Robert D Newman, et al.
Current Opinion in Infectious Diseases|November 3, 2007
Intermittent preventive therapy for malaria: progress and future directionsMartin P Grobusch, Andrea Egan, Roly D Gosling, et al.
Annals of Internal Medicine|October 7, 2004
Malaria-related deaths among U.S. travelers, 1963-2001Robert D Newman, Monica E Parise, Ann M Barber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002Louise M Causer, Scott Filler, Marianna Wilson, et al.
Drug Safety|June 1, 2007
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatmentPhilip J Peters, Michael C Thigpen, Monica E Parise, et al.
Tropical Medicine & International Health : TM & IH|June 7, 2003
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan AfricaRobert D Newman, Monica E Parise, Laurence Slutsker, et al.
Lancet (London, England)|January 27, 2009
Neglected tropical diseases and the Global FundDavid H Molyneux, Peter J Hotez, Alan Fenwick, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|November 8, 2002
Malaria surveillance--United States, 1999Robert D Newman, Ann M Barber, Jacquelin Roberts, et al.
The Lancet. Infectious Diseases|January 26, 2007
Epidemiology and burden of malaria in pregnancyMeghna Desai, Feiko O ter Kuile, François Nosten, et al.
Pageof 6